DKS

DICK'S Sporting Goods, Inc.

45
Fundamentals48/ 100
Valuation40/ 100
Upside potential64/ 100
Risk potential19/ 100

DKS has lower modeled downside risk, despite its lower overall score.

GME

GameStop Corp.

49
Fundamentals73/ 100
Valuation61/ 100
Upside potential32/ 100
Risk potential51/ 100

GME has the edge over DKS overall, supported by stronger fundamentals and stronger valuation.

DKS Fundamentals

MetricStatus
Strong
Stable
Under pressure
Healthy

DKS's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.

GME Fundamentals

MetricStatus
Stable
Strong
Strong
Unavailable

GME's profitability and cash flow are currently strong, and its revenue is stable. There isn't enough data to rate its balance sheet.

DKS PE Valuation

CHEAPFAIREXPENSIVE12x24x35x47x
CHEAPFAIREXPENSIVE12x24x35x47x
LevelPEPriceVs current
Cheap9.3x$84.34-42%
Forward12x$146—
Fair14x$124-15%
Current16x$146—
Expensive18x$162+11%

Historical ranges are pointers, not guarantees.

DKS's PE is in its expensive range at 16x. If earnings grow as analysts expect, today's price would be 12x next year's earnings, in its fair range.

GME PE Valuation

CHEAPFAIREXPENSIVE367x734x1101x1467x
CHEAPFAIREXPENSIVE367x734x1101x1467x
LevelPEPriceVs current
Current17x$25.62—
Cheap18x$27.96+9.1%
Forward38x$25.62—
Fair43x$66.84+161%
Expensive252x$388+1414%

Historical ranges are pointers, not guarantees.

GME has the edge over DKS in the historical PE scenario, which offers more potential upside but is not a forecast.

DKS Forward outlook

MetricOutlook
Strongly improving
Growth
Stable
Improving
Limited
Moderate

DKS has the edge over GME on the outlook, with more favorable valuation and earnings expectations.

GME Forward outlook

MetricOutlook
Strongly deteriorating
Strong decline
Strong decline
Strongly weakening
Limited
High

Analysts expect GME's earnings and revenue to decline, with profitability weakening.

DKS Risk to reward

ScenarioChangePrice
Upside+33%$193.88
Downside-19%$118.44

Calculated from the latest close: $145.66 on Nov 12.

DKS has a better modeled risk to reward balance than GME, with more potential upside and less potential downside.

GME Risk to reward

ScenarioChangePrice
Upside+24%$31.72
Downside-51%$12.64

Calculated from the latest close: $25.62 on Nov 12.

GME trails DKS on modeled risk to reward, with less potential upside and more potential downside.

DKS Earnings Per Share

Q4 2023: $11.22Q1 2024: $12.18Q2 2024: $12.08Q3 2024: $13.63Q4 2024: $13.99Q1 2025: $14.05Q2 2025: $13.99Q3 2025: $14.33Q4 2025: $12.44Q1 2026: $9.97Q2 2026: $10.27Q3 2026: $9.06Forward: $12.44
Q4 2023: $11.22Q1 2024: $12.18Q2 2024: $12.08Q3 2024: $13.63Q4 2024: $13.99Q1 2025: $14.05Q2 2025: $13.99Q3 2025: $14.33Q4 2025: $12.44Q1 2026: $9.97Q2 2026: $10.27Q3 2026: $9.06Forward: $12.44
QuarterTTM EPSYoY
Forward$12.44+37%
Q3 2026$9.06-37%
Q2 2026$10.27-27%
Q1 2026$9.97-29%
Q4 2025$12.44-11%
Q3 2025$14.33+5.1%
Q2 2025$13.99+16%
Q1 2025$14.05+15%
Q4 2024$13.99+25%

DKS's earnings per share have fallen from their peak: $9.06 over the past year, against $14.33 in mid-2025.

GME Earnings Per Share

Q4 2023: $-0.03Q1 2024: $0.02Q2 2024: $0.08Q3 2024: $0.13Q4 2024: $0.18Q1 2025: $0.33Q2 2025: $0.53Q3 2025: $0.80Q4 2025: $0.89Q1 2026: $0.77Q2 2026: $1.34Q3 2026: $1.54Forward: $0.67
Q4 2023: $-0.03Q1 2024: $0.02Q2 2024: $0.08Q3 2024: $0.13Q4 2024: $0.18Q1 2025: $0.33Q2 2025: $0.53Q3 2025: $0.80Q4 2025: $0.89Q1 2026: $0.77Q2 2026: $1.34Q3 2026: $1.54Forward: $0.67
QuarterTTM EPSYoY
Forward$0.67-56%
Q3 2026$1.54+93%
Q2 2026$1.34+153%
Q1 2026$0.77+133%
Q4 2025$0.89+394%
Q3 2025$0.80+515%
Q2 2025$0.53+563%
Q1 2025$0.33+1550%
Q4 2024$0.18+$0.21

GME has the edge over DKS on earnings, with more consistent year-over-year improvement.

DKS Quarterly Revenue

Q4 2023: $3BQ1 2024: $3.9BQ2 2024: $3BQ3 2024: $3.5BQ4 2024: $3.1BQ1 2025: $3.9BQ2 2025: $3.2BQ3 2025: $3.6BQ4 2025: $4.2BQ1 2026: $6.2BQ2 2026: $5.2BQ3 2026: $5.6B
Q4 2023: $3BQ1 2024: $3.9BQ2 2024: $3BQ3 2024: $3.5BQ4 2024: $3.1BQ1 2025: $3.9BQ2 2025: $3.2BQ3 2025: $3.6BQ4 2025: $4.2BQ1 2026: $6.2BQ2 2026: $5.2BQ3 2026: $5.6B
QuarterRevenueYoY
Q3 2026$5.6B+53%
Q2 2026$5.2B+63%
Q1 2026$6.2B+60%
Q4 2025$4.2B+36%
Q3 2025$3.6B+5%
Q2 2025$3.2B+5.2%
Q1 2025$3.9B+0.5%
Q4 2024$3.1B+0.5%

DKS has the edge over GME on sales, with more consistent year-over-year improvement.

GME Quarterly Revenue

Q4 2023: $1.1BQ1 2024: $1.8BQ2 2024: $882MQ3 2024: $798MQ4 2024: $860MQ1 2025: $1.3BQ2 2025: $732MQ3 2025: $972MQ4 2025: $821MQ1 2026: $1.1BQ2 2026: $835MQ3 2026: $790M
Q4 2023: $1.1BQ1 2024: $1.8BQ2 2024: $882MQ3 2024: $798MQ4 2024: $860MQ1 2025: $1.3BQ2 2025: $732MQ3 2025: $972MQ4 2025: $821MQ1 2026: $1.1BQ2 2026: $835MQ3 2026: $790M
QuarterRevenueYoY
Q3 2026$790.2M-19%
Q2 2026$835.3M+14%
Q1 2026$1.1B-14%
Q4 2025$821M-4.6%
Q3 2025$972.2M+22%
Q2 2025$732.4M-17%
Q1 2025$1.3B-28%
Q4 2024$860.3M-20%

GME's revenue has slid since its 2022 peak: $790M last quarter, down 19% from the same quarter a year ago.

DKS Free Cash Flow

Q4 2023: −$90MQ1 2024: $585MQ2 2024: $74MQ3 2024: $180MQ4 2024: −$139MQ1 2025: $395MQ2 2025: −$87MQ3 2025: $296MQ4 2025: −$516MQ1 2026: $706MQ2 2026: −$84MQ3 2026: $133M
Q4 2023: −$90MQ1 2024: $585MQ2 2024: $74MQ3 2024: $180MQ4 2024: −$139MQ1 2025: $395MQ2 2025: −$87MQ3 2025: $296MQ4 2025: −$516MQ1 2026: $706MQ2 2026: −$84MQ3 2026: $133M
QuarterFree cash flowYoY
Q3 2026$133M-55%
Q2 2026-$84.2M+$2.5M
Q1 2026$706.2M+79%
Q4 2025-$515.6M-$376.3M
Q3 2025$296.2M+65%
Q2 2025-$86.7M-217%
Q1 2025$394.5M-33%
Q4 2024-$139.3M-$49.6M

DKS still generates free cash flow, though less than at its 2020 peak: $239M over the past year.

GME Free Cash Flow

Q4 2023: $11MQ1 2024: −$19MQ2 2024: −$115MQ3 2024: $66MQ4 2024: $20MQ1 2025: $159MQ2 2025: $190MQ3 2025: $113MQ4 2025: $107MQ1 2026: $187MQ2 2026: $333MQ3 2026: $61M
Q4 2023: $11MQ1 2024: −$19MQ2 2024: −$115MQ3 2024: $66MQ4 2024: $20MQ1 2025: $159MQ2 2025: $190MQ3 2025: $113MQ4 2025: $107MQ1 2026: $187MQ2 2026: $333MQ3 2026: $61M
QuarterFree cash flowYoY
Q3 2026$60.7M-46%
Q2 2026$332.9M+76%
Q1 2026$187.4M+18%
Q4 2025$107M+435%
Q3 2025$113.3M+73%
Q2 2025$189.6M+$304.3M
Q1 2025$158.8M+$177.5M
Q4 2024$20M+80%

GME has the edge over DKS on cash flow, with more consistent year-over-year improvement.

DKS Total Shares

Q4 2023: 84MQ1 2024: 86MQ2 2024: 83MQ3 2024: 83MQ4 2024: 83MQ1 2025: 83MQ2 2025: 81MQ3 2025: 81MQ4 2025: 87MQ1 2026: 85MQ2 2026: 90MQ3 2026: 90M
Q4 2023: 84MQ1 2024: 86MQ2 2024: 83MQ3 2024: 83MQ4 2024: 83MQ1 2025: 83MQ2 2025: 81MQ3 2025: 81MQ4 2025: 87MQ1 2026: 85MQ2 2026: 90MQ3 2026: 90M
PeriodChange %Net change
Quarterly-0.3%-277K shares
1 year+11%+9.1M shares
3 years+3.9%+3.3M shares
5 years-18%-19.1M shares
Available history+4.1%+3.5M shares

DKS has 90M diluted shares, up 11% from a year ago, despite $185M in buybacks over the past year.

GME Total Shares

Q4 2023: 305MQ1 2024: 305MQ2 2024: 306MQ3 2024: 387MQ4 2024: 438MQ1 2025: 395MQ2 2025: 498MQ3 2025: 547MQ4 2025: 592MQ1 2026: 549MQ2 2026: 592MQ3 2026: 593M
Q4 2023: 305MQ1 2024: 305MQ2 2024: 306MQ3 2024: 387MQ4 2024: 438MQ1 2025: 395MQ2 2025: 498MQ3 2025: 547MQ4 2025: 592MQ1 2026: 549MQ2 2026: 592MQ3 2026: 593M
PeriodChange %Net change
Quarterly+0.1%+300K shares
1 year+8.4%+46.1M shares
3 years+94%+288M shares
5 years+104%+302M shares
Available history+80%+264M shares

GME has the edge over DKS on shareholder dilution, with a more favorable share count trend.

DKS Net Leverage

Q4 2023: 0.1xQ1 2024: -0.2xQ2 2024: -0.1xQ3 2024: -0.1xQ4 2024: 0.0xQ1 2025: -0.1xQ2 2025: 0.2xQ3 2025: 0.1xQ4 2025: 0.6xQ1 2026: 0.4xQ2 2026: 0.5xQ3 2026: 0.6x
Q4 2023: 0.1xQ1 2024: -0.2xQ2 2024: -0.1xQ3 2024: -0.1xQ4 2024: 0.0xQ1 2025: -0.1xQ2 2025: 0.2xQ3 2025: 0.1xQ4 2025: 0.6xQ1 2026: 0.4xQ2 2026: 0.5xQ3 2026: 0.6x
QuarterNet LeverageStatus
Q3 20260.6xVery low
Q2 20260.5xVery low
Q1 20260.4xVery low
Q4 20250.6xVery low
Q3 20250.1xVery low
Q2 20250.2xVery low
Q1 2025-0.1xNet Cash
Q4 20240.0xVery low

DKS's net debt is less than a year of its operating earnings (EBITDA).

GME Net Leverage

DKS Weekly Momentum

MetricValueStatus
RSI38.2Neutral
Stochastic24.3Neutral

DKS's weekly RSI is 38 (neutral) and its Stochastic is 24 (neutral).

GME Weekly Momentum

MetricValueStatus
RSI59.9Neutral
Stochastic68.5Neutral

GME's weekly RSI is 60 (neutral) and its Stochastic is 69 (neutral).

DKS PE vs Consumer Cyclical Sector

MetricDKSSector medianRelative
PE16x18x11% below
PE %714724 pts above

DKS has the edge over GME on valuation relative to its sector.

GME PE vs Consumer Cyclical Sector

MetricGMESector medianRelative
PE17x18x7.7% below
PE %154732 pts below

GME is trading at 17x earnings, in line with the Consumer Cyclical sector's median of 18x.

DKS Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$141.13.3% above
20 week MA$166.312% below
50 week MA$194.225% below
100 week MA$202.528% below
200 week MA$184.021% below

DKS has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 21% below its 200-week average.

GME Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$25.21.8% above
20 week MA$22.415% above
50 week MA$22.613% above
100 week MA$24.07% above
200 week MA$21.817% above

GME has the edge over DKS on trend strength, trading above more of its moving averages.

DKS Yearly ROI

YearStart priceEnd priceROI
2020$48.2$55.6+15%
2021$55.6$103.9+87%
2022$103.9$111.1+6.9%
2023$111.1$147.0+32%
2024$147.0$234.1+59%
2025$234.1$210.3-10%
2026 YTD$210.3$145.7-31%

DKS is down 31% so far in 2026, after finishing higher in five of the previous six years.

GME Yearly ROI

YearStart priceEnd priceROI
2020$1.48$5.04+241%
2021$5.04$38.0+655%
2022$38.0$20.1-47%
2023$20.1$17.5-13%
2024$17.5$32.2+84%
2025$32.2$21.1-35%
2026 YTD$21.1$25.6+21%

GME has the edge over DKS on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key